# OnCo record her2climb-02 (trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/trials/her2climb-02/>
  a schema:MedicalTrial ;
  onco:kind "trial" ;
  schema:identifier "her2climb-02", "NCT03975647" ;
  schema:name "HER2CLIMB-02"@en ;
  schema:description "Adding tucatinib to Kadcyla helped a little, mostly in patients with brain metastases, but did not extend survival."@en ;
  schema:url <https://onco.cc/trials/her2climb-02/> ;
  schema:dateModified "2026-09-07"^^xsd:date ;
  schema:citation <https://clinicaltrials.gov/study/NCT03975647> ;
  onco:status "mixed" ;
  onco:phase "3" ;
  schema:startDate "2019-10-02" ;
  onco:cancers <https://onco.cc/cancers/breast-her2-positive/>, <https://onco.cc/cancers/her2-positive-breast-brain-metastases/> ;
  onco:technologies <https://onco.cc/technologies/her2-tyrosine-kinase-inhibitors/>, <https://onco.cc/technologies/kinase-inhibitors/> ;
  onco:drugs <https://onco.cc/drugs/tucatinib/>, <https://onco.cc/drugs/trastuzumab-emtansine/> ;
  onco:companies <https://onco.cc/companies/pfizer/> ;
  onco:keyPapers <https://onco.cc/key-papers/paper-her2climb-02-ann-oncol-2026/> .